Literature DB >> 6178687

Effect of cyclosporin A on murine natural killer cells.

X Gui, M Ho, P E Camp.   

Abstract

In mice, cyclosporin A decreased the natural killer cell-enhancing effect of two interferon inducers, infective murine cytomegalovirus and nonreplicating Newcastle disease virus. It also inhibited murine cytomegalovirus replication at doses greater than 20 mg/kg, but it did not significantly inhibit interferon induction by Newcastle disease virus. In cell culture, cyclosporin A had no direct effect on the natural killer activity of spleen mononuclear cells derived from normal or murine cytomegalovirus-infected animals. However, at 50 micrograms/ml it significantly reduced the ability of interferon to enhance the natural killer activity of normal spleen cell suspensions. The inhibitory effect of cyclosporin A on natural killer cell activity in infected mice may be partly explained by its ability to block the action of interferon.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6178687      PMCID: PMC551447          DOI: 10.1128/iai.36.3.1123-1127.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Biological effects of cyclosporin A: a new antilymphocytic agent.

Authors:  J F Borel; C Feurer; H U Gubler; H Stähelin
Journal:  Agents Actions       Date:  1976-07

2.  The role of natural killer cells and antibody-dependent cell-mediated cytotoxicity during murine cytomegalovirus infection.

Authors:  G V Quinnan; J E Manischewitz
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

3.  Semi-micro, dye-binding assay for rabbit interferon.

Authors:  J A Armstrong
Journal:  Appl Microbiol       Date:  1971-04

4.  Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft.

Authors:  D H Crawford; J A Thomas; G Janossy; P Sweny; O N Fernando; J F Moorhead; J H Thompson
Journal:  Lancet       Date:  1980-06-21       Impact factor: 79.321

5.  Enhanced NK cell activity in mice injected with interferon and interferon inducers.

Authors:  M Gidlund; A Orn; H Wigzell; A Senik; I Gresser
Journal:  Nature       Date:  1978-06-29       Impact factor: 49.962

6.  Comparative study of in vitro and in vivo drug effects on cell-mediated cytotoxicity.

Authors:  J F Borel
Journal:  Immunology       Date:  1976-10       Impact factor: 7.397

7.  Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR.

Authors:  A D Hess; P J Tutschka
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

8.  Effect of cyclosporin A on human lymphocyte responses in vitro. II. Induction of specific alloantigen unresponsiveness mediated by a nylon wool adherent suppressor cell.

Authors:  A D Hess; P J Tutschka; G W Santos
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

9.  Effects of the new anti-lymphocytic peptide cyclosporin A in animals.

Authors:  J F Borel; C Feurer; C Magnée; H Stähelin
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

10.  The use of cyclosporin A and prednisone in cadaver kidney transplantation.

Authors:  T E Starzl; R Weil; S Iwatsuki; G Klintmalm; G P Schröter; L J Koep; Y Iwaki; P I Terasaki; K A Porter
Journal:  Surg Gynecol Obstet       Date:  1980-07
View more
  6 in total

1.  Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection.

Authors:  K B Lemström; J H Bruning; C A Bruggeman; I T Lautenschlager; P J Häyry
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

2.  Improved outcome of renal transplantation with cyclosporine compared with azathioprine--experience in 33 recipients followed for over one year.

Authors:  T Yasumura; Y Ohmori; I Aikawa; M Fukuda; S Suzuki; I Nakai; S Matsui; T Oka
Journal:  Jpn J Surg       Date:  1986-05

3.  Cyclosporine inhibits mouse cytomegalovirus infection via a cyclophilin-dependent pathway specifically in neural stem/progenitor cells.

Authors:  Hideya Kawasaki; Edward S Mocarski; Isao Kosugi; Yoshihiro Tsutsui
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

4.  Natural killer cell activity in renal transplant recipients receiving cyclosporine.

Authors:  X E Gui; C R Rinaldo; M Ho
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

5.  Inhibition of cyclophilin A suppresses H2O2-enhanced replication of HCMV through the p38 MAPK signaling pathway.

Authors:  Jun Xiao; Xin Song; Jiang Deng; Liping Lv; Ping Ma; Bo Gao; Xipeng Zhou; Yanyu Zhang; Jinbo Xu
Journal:  FEBS Open Bio       Date:  2016-08-15       Impact factor: 2.693

6.  Effect of cyclosporin A on an experimental chronic viral infection of the central nervous system.

Authors:  O Boespflug; C Godfraind; M Tardieu
Journal:  J Neuroimmunol       Date:  1989-01       Impact factor: 3.478

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.